A Proof-of-Concept, Multicenter, Randomized, Double-Blind, Parallel Study of Naltrexone Sustained-Release (SR) and/or Fluoxetine Therapy in the Treatment of Subjects With Obsessive-Compulsive Disorder (OCD).
Phase of Trial: Phase II
Latest Information Update: 28 Nov 2012
At a glance
- Drugs Fluoxetine (Primary) ; Naltrexone (Primary)
- Indications Obsessive-compulsive disorders
- Focus Therapeutic Use
- 12 Feb 2010 Actual patient number (8) added as reported by ClinicalTrials.gov.
- 11 Oct 2008 New trial record.